127 related articles for article (PubMed ID: 15867421)
1. Chromosome 7 deletions are associated with unfavorable prognosis in myelofibrosis with myeloid metaplasia.
Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Gisslinger H; Zojer N; Ludwig H
Blood; 2005 May; 105(10):4146. PubMed ID: 15867421
[No Abstract] [Full Text] [Related]
2. The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course.
Tam CS; Abruzzo LV; Lin KI; Cortes J; Lynn A; Keating MJ; Thomas DA; Pierce S; Kantarjian H; Verstovsek S
Blood; 2009 Apr; 113(18):4171-8. PubMed ID: 19131547
[TBL] [Abstract][Full Text] [Related]
3. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic myelofibrosis in blast transformation with 4;12 and 5;12 translocations and a 7q deletion.
Przepiorka D; Bryant E; Kidd P
Cancer Genet Cytogenet; 1988 Jan; 30(1):139-44. PubMed ID: 3422039
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia.
Tefferi A; Mesa RA; Schroeder G; Hanson CA; Li CY; Dewald GW
Br J Haematol; 2001 Jun; 113(3):763-71. PubMed ID: 11380468
[TBL] [Abstract][Full Text] [Related]
6. AML with myelodysplasia-related changes masquerades as acute panmyelosis with myelofibrosis.
Xu Z
Blood; 2017 Oct; 130(15):1775. PubMed ID: 29025719
[No Abstract] [Full Text] [Related]
7. The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan.
Hidaka T; Shide K; Shimoda H; Kameda T; Toyama K; Katayose K; Kubuki Y; Nagata K; Takenaka K; Akashi K; Okamura T; Niho Y; Mizoguchi H; Omine M; Ozawa K; Harada M; Shimoda K
Eur J Haematol; 2009 Oct; 83(4):328-33. PubMed ID: 19549278
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of isolated del(7p) in myeloid neoplasms.
Gur HD; Wang SA; Tang Z; Hu S; Li S; Medeiros LJ; Tang G
Leuk Res; 2017 Apr; 55():18-22. PubMed ID: 28119224
[TBL] [Abstract][Full Text] [Related]
9. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
Tefferi A; Dingli D; Li CY; Dewald GW
Cancer; 2005 Oct; 104(8):1656-60. PubMed ID: 16104040
[TBL] [Abstract][Full Text] [Related]
10. A unifying diagnosis for pancytopenia, fever, hypoglycemia, and lactic acidosis.
Kloesel B; Vaidya R; Howard MT; Thompson CA
Am J Hematol; 2013 Jan; 88(1):78-81. PubMed ID: 22460726
[No Abstract] [Full Text] [Related]
11. Coexistence of tetrasomy 8 and trisomy 8 in a case with myeloid metaplasia with myelofibrosis.
Solé F; de Pablos JM; Woessner S; Pérez MM; Jurado M; Espinet B; Grao P; Moratalla A; Esquivias J
Cancer Genet Cytogenet; 1997 Apr; 94(2):147-50. PubMed ID: 9109946
[TBL] [Abstract][Full Text] [Related]
12. Coincidence between fragile site expression and interstitial deletion of chromosome 11 in a case of myelofibrosis.
Sessarego M; Ajmar F; Ravazzolo R; Bianchi Scarrà GL; Garrè C; Boccaccio P
Hum Genet; 1983; 63(3):299-301. PubMed ID: 6852829
[TBL] [Abstract][Full Text] [Related]
13. Isochromosome 17q in a case of myelofibrosis with myeloid metaplasia terminating in blastic transformation.
Nakamura H; Sadamori N; Yamada Y; Yao E; Tagawa M; Nishino K; Sasagawa I; Kamihira S; Oyakawa Y; Tomonaga M
Cancer Genet Cytogenet; 1987 Feb; 24(2):221-4. PubMed ID: 3791175
[TBL] [Abstract][Full Text] [Related]
14. Chromosome aberrations including der(6)t(2;6)(p15;p21.3) and der(22)t(3;22)(p21;p11) in the evolution of essential thrombocythemia to myelofibrosis with myeloid metaplasia.
Lazarevic V; Andersson C; Wahlin A; Golovleva I
Cancer Genet Cytogenet; 2006 Feb; 165(1):87-9. PubMed ID: 16490605
[No Abstract] [Full Text] [Related]
15. Chromosome deletion [46,XX,del(20)(q11)] in agnogenic myeloid metaplasia.
Findley L; Kurnick JE; Peakman DC; Robinson A
Hum Genet; 1979 Mar; 47(2):207-11. PubMed ID: 437786
[TBL] [Abstract][Full Text] [Related]
16. Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia.
Andrieux J; Demory JL; Morel P; Plantier I; Dupriez B; Caulier MT; Bauters F; Laï JL
Cancer Genet Cytogenet; 2002 Aug; 137(1):68-71. PubMed ID: 12377417
[TBL] [Abstract][Full Text] [Related]
17. Myelofibrosis in myeloid malignancies with 3q26 cytogenetic abnormalities.
Sancho JM; Ribera JM; Granada I; Navarro JT; Millá F; Feliu E
Haematologica; 2000 May; 85(5):554-5. PubMed ID: 10800180
[No Abstract] [Full Text] [Related]
18. Novel CUX1 missense mutation in association with 7q- at leukemic transformation of MPN.
Thoennissen NH; Lasho T; Thoennissen GB; Ogawa S; Tefferi A; Koeffler HP
Am J Hematol; 2011 Aug; 86(8):703-5. PubMed ID: 21674579
[No Abstract] [Full Text] [Related]
19. [Agnogenic myeloid metaplasia with eosinophilia].
Vidović A; Jovanović V; Novak A; Basara N; Janković G
Srp Arh Celok Lek; 1996; 124(11-12):314-7. PubMed ID: 9132967
[TBL] [Abstract][Full Text] [Related]
20. Trisomy 14, deletion 20q and t(3;3) (q21;q26) in a case of myelodysplastic syndrome with myelofibrosis.
Kwong YL; Wan TS; Liang R; Chan LC
Clin Lab Haematol; 1994 Mar; 16(1):79-84. PubMed ID: 8039350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
